<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0018329"><a href="http://purl.obolibrary.org/obo/MONDO_0018329">MONDO:0018329</a></h3>
<p><strong>Label:</strong> persistent combined dystonia</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0008840">MONDO:0008840</a> (ataxia telangiectasia), <a href="http://purl.obolibrary.org/obo/MONDO_0016812">MONDO:0016812</a> (Dopa-responsive dystonia), <a href="http://purl.obolibrary.org/obo/MONDO_0011551">MONDO:0011551</a> (autosomal recessive dopa-responsive dystonia), <a href="http://purl.obolibrary.org/obo/MONDO_0000903">MONDO:0000903</a> (myoclonus-dystonia syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0008044">MONDO:0008044</a> (myoclonic dystonia 11), <a href="http://purl.obolibrary.org/obo/MONDO_0018266">MONDO:0018266</a> (ataxia-telangiectasia variant),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_100">Orphanet:100</a>, <a href="http://www.orpha.net/ORDO/Orphanet_370109">Orphanet:370109</a>, <a href="http://www.orpha.net/ORDO/Orphanet_255">Orphanet:255</a>, <a href="http://purl.obolibrary.org/obo/OMIM_208910">OMIM:208910</a>, <a href="http://purl.obolibrary.org/obo/OMIM_208900">OMIM:208900</a>, <a href="http://www.orpha.net/ORDO/Orphanet_36899">Orphanet:36899</a>, <a href="http://purl.obolibrary.org/obo/OMIM_159900">OMIM:159900</a>, <a href="http://www.orpha.net/ORDO/Orphanet_101150">Orphanet:101150</a>, <a href="http://purl.obolibrary.org/obo/OMIM_605407">OMIM:605407</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616398">OMIM:616398</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004313">HP:0004313</a> (Decreased antibody level in blood) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000777">HP:0000777</a> (Abnormality of the thymus) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) and <a href="http://purl.obolibrary.org/obo/HP_0011446">HP:0011446</a> (Abnormality of higher mental function) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) and <a href="http://purl.obolibrary.org/obo/HP_0011014">HP:0011014</a> (Abnormal glucose homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) and <a href="http://purl.obolibrary.org/obo/HP_0011013">HP:0011013</a> (Abnormality of carbohydrate metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010701">HP:0010701</a> (Abnormal immunoglobulin level) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010701">HP:0010701</a> (Abnormal immunoglobulin level) and <a href="http://purl.obolibrary.org/obo/HP_0011446">HP:0011446</a> (Abnormality of higher mental function) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010701">HP:0010701</a> (Abnormal immunoglobulin level) and <a href="http://purl.obolibrary.org/obo/HP_0011014">HP:0011014</a> (Abnormal glucose homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010701">HP:0010701</a> (Abnormal immunoglobulin level) and <a href="http://purl.obolibrary.org/obo/HP_0011013">HP:0011013</a> (Abnormality of carbohydrate metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005372">HP:0005372</a> (Abnormality of B cell physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005372">HP:0005372</a> (Abnormality of B cell physiology) and <a href="http://purl.obolibrary.org/obo/HP_0011446">HP:0011446</a> (Abnormality of higher mental function) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005372">HP:0005372</a> (Abnormality of B cell physiology) and <a href="http://purl.obolibrary.org/obo/HP_0011014">HP:0011014</a> (Abnormal glucose homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005372">HP:0005372</a> (Abnormality of B cell physiology) and <a href="http://purl.obolibrary.org/obo/HP_0011013">HP:0011013</a> (Abnormality of carbohydrate metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0100579">HP:0100579</a> (Mucosal telangiectasiae) 65.00%</li>
</ul>
</body>
</html>
